JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

JNJ

190.6

-0.77%↓

ABT

126.77

+0.33%↑

MDT

93.77

-0.45%↓

VEEV

293.21

+0.68%↑

A

148.21

+0.39%↑

Search

Viatris Inc

Fermé

SecteurSoins de santé

10.36 0.58

Résumé

Variation du prix de l'action

24h

Actuel

Min

10.3

Max

10.49

Chiffres clés

By Trading Economics

Revenu

3B

-4.6M

Ventes

328M

3.6B

Rendement du dividende

4.72

Marge bénéficiaire

-0.128

Employés

32,000

EBITDA

2.9B

578M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+10.47% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

4.72%

2.33%

Prochains Résultats

6 nov. 2025

Date du Prochain Dividende

12 déc. 2025

Date du Prochain Détachement de Dividende

21 nov. 2025

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

1.5B

12B

Ouverture précédente

9.78

Clôture précédente

10.36

Score Technique

By Trading Central

Confiance

Bullish Evidence

Viatris Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

9 oct. 2025, 09:10 UTC

Actions en Tendance

Stocks to Watch Thursday: HSBC, PepsiCo, MP Materials -- WSJ

Comparaison

Variation de prix

Viatris Inc prévision

Objectif de Prix

By TipRanks

10.47% hausse

Prévisions sur 12 Mois

Moyen 11.5 USD  10.47%

Haut 15 USD

Bas 8 USD

Basé sur 4 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

4 ratings

1

Achat

2

Maintien

1

Vente

Score Technique

By Trading Central

8.48 / N/ASupport & Résistance

Court Terme

Bullish Evidence

Moyen Terme

Very Strong Bullish Evidence

Long Terme

Strong Bearish Evidence

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Viatris Inc

Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, including noncommunicable and infectious diseases; biosimilars in the areas of oncology, immunology, endocrinology, ophthalmology, and dermatology; and APIs for antibacterial, central nervous system agents, antihistamines/antiasthmatics, cardiovascular, antivirals, antidiabetics, antifungals, and proton pump inhibitor areas, as well as support services, such as diagnostic clinics, educational seminars, and digital tools to help patients better manage their health. It provides it medicines in the form of oral solid doses, injectables, complex dosage forms, and APIs to retail and pharmacy establishments, wholesalers and distributors, payers, insurers and governments, and institutions. The company distributes its products through pharmaceutical wholesalers/distributors, pharmaceutical retailers, institutional pharmacies, mail-order and e-commerce pharmacies, and specialty pharmacies. It sells its products under the Lyrica, Lipitor, Creon, Influvac, Wixela Inhub, EpiPen auto-injector, Fraxiparine, and Yupelri; Norvasc and Viagra; AMITIZA, Lipacreon, and Effexor; and Celebrex and ARV names, as well as glargine and SEMGLEE names. The company has collaboration and licensing agreements with Revance Therapeutics, Inc.; and Momenta Pharmaceuticals, Inc. Viatris Inc. was founded in 1961 and is headquartered in Canonsburg, Pennsylvania.
help-icon Live chat